BINHUI BIOPHARM

BINHUI BIOPHARM

Twenty years in oncolytic virus research and development        

for a new chapter of tumor immunotherapy


Oncolytic Virus

oHSV2-OH2

oHSV2-Cocktail

oHSV2-BiTEs

Vaccine platform

Recombinant protein vaccine

Nucleic acid vaccine

Product Pipeline

Developed multiple indication products based on the oncolytic virus immunotherapy and vaccine platform